High-Cost Drug Reimbursement
Customize your policy alerts
Sign up for wellfleet Policy GL-023 alerts
Get alerted when Policy GL-023 changes without checking for updates manually.
Monitor payer policy activity
This guideline governs Wellfleet reimbursement for high-cost drugs billed under a member's medical benefit when the drugs are separately reimbursed from other claim line items. It applies to providers submitting claims for applicable Wellfleet plans, subject to the member's benefit document, provider agreement, applicable mandates, and any required precertification.
No material clinical or coverage changes in this revision.
Eligibility for High-Cost Drug Reimbursement
Eligibility for High-Cost Drug Reimbursement
Wellfleet will reimburse up to two times the listed Average Wholesale Price (AWP) for High-Cost Drugs submitted under a member's Medical Benefit when ALL of the following conditions are met. Self-Administered drugs are subject to the Self-Administered Medications Guideline first; if that guideline is not applicable, this High-Cost Drug guideline is reviewed. Medical records may be requested to support billed dosing amounts.
ALL of the following
- The High-Cost Drug is a prescription medication costing over $10,000 per 30-day supply that requires special handling, administration, or monitoring and is covered under both medical and pharmacy benefits, typically for complex and/or chronic conditions.
- The High-Cost Drug is a covered Medical Benefit under an eligible member's Plan.
- The High-Cost Drug is submitted as an individual line item on a medical claim.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.